<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><strong><u>YAWS</u></strong></p><p>Yaws is a chronic infection by a bacterium that affects mainly the skin, bone and cartilage. Most people affected are children under 15 years of age but adults are not exempt. It is transmitted mainly through skin contact with an infected person. A single skin lesion develops at the point of entry of the bacterium after 24 weeks. Without treatment, multiple lesions appear all over the body. The disease is rarely fatal, however it can lead to chronic disfigurement and disability in about 10% of affected individuals if left untreated. Treatment with antibiotics is curative and relapse is rare. Overcrowding, poor personal hygiene and poor sanitation facilitate the spread of the disease.</p><p> </p><p><strong>CAUSES</strong></p><ul><li><i>Treponema pertenue</i></li></ul><p> </p><p><strong>SYMPTOMS</strong></p><ul><li>Raised skin lesions</li><li>Painless skin ulcer</li><li>Bone pain</li></ul><p> </p><p><strong>SIGNS</strong></p><ul><li>Papular skin lesions</li><li>Painless skin ulcer with scab</li><li>Deformities of the nose, bones</li><li>Palmar or plantar skin thickening</li></ul><p> </p><p><strong>INVESTIGATIONS</strong></p><ul><li>VDRL</li></ul><p> </p><p><strong>TREATMENT </strong></p><p><strong>Treatment objectives</strong></p><ul><li>To eradicate the organism and ensure cure</li><li>To prevent spread of the infection</li><li>To prevent long term complications</li></ul><p> </p><p> </p><p><strong>Non-pharmacological treatment</strong></p><ul><li>None</li></ul><p> </p><p><strong>Pharmacological treatment</strong></p><p>Evidence Rating: [A]</p><ol><li><strong>Single Dose Treatment for Yaws</strong></li></ol><ul><li>Azithromycin, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>30 mg/kg body weight (max. 2 g) as a single dose</p><p><strong><u>Children</u></strong></p><p>&gt;15 years;  2 g</p><p>10-15 years;  1.5 g</p><p>6-9 years;  1 g</p><p>6 months-6 years;  500 mg (syrup preferable)</p><p>&lt; 6 months;  not recommended</p><ol><li><strong>For Non-response or Non-availability of Azithromycin</strong></li></ol><ul><li>Benzathine Penicillin, IM,</li></ul><p><strong><u>Adults</u></strong></p><p>1.2 million units stat.</p><p><strong><u>Children</u></strong></p><p>&gt;10 years;  1.2 MU stat.</p><p>&lt; 10 years; 600 000 units stat.</p><p> </p><p><strong>REFERRAL CRITERIA</strong></p><p>Refer intractable cases to the dermatologist.</p><p> </p><p> </p><p> </p>
</body>
</html>
